125 related articles for article (PubMed ID: 32675544)
1. Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation.
Harada K; Wu CC; Wang X; Mizrak Kaya D; Amlashi FG; Iwatsuki M; Blum Murphy MA; Maru DM; Weston B; Lee JH; Rogers JE; Thomas I; Shanbhag N; Bhutani MS; Hofstetter WL; Nguyen QN; Ajani JA
Ann Surg; 2020 Aug; 272(2):311-318. PubMed ID: 32675544
[TBL] [Abstract][Full Text] [Related]
2. Low metabolic activity in primary gastric adenocarcinoma is associated with resistance to chemoradiation and the presence of signet ring cells.
Harada K; Patnana M; Wang X; Iwatsuki M; Murphy MAB; Zhao M; Das P; Minsky BD; Weston B; Lee JH; Bhutani MS; Estrella JS; Shanbhag N; Ikoma N; Badgwell BD; Ajani JA
Surg Today; 2020 Oct; 50(10):1223-1231. PubMed ID: 32409870
[TBL] [Abstract][Full Text] [Related]
3.
Mantziari S; Pomoni A; Prior JO; Winiker M; Allemann P; Demartines N; Schäfer M
BMC Med Imaging; 2020 Jan; 20(1):7. PubMed ID: 31969127
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of metabolic tumor volume and total lesion glycolysis in esophageal carcinoma patients treated with definitive chemoradiotherapy.
Yildirim BA; Torun N; Guler OC; Onal C
Nucl Med Commun; 2018 Jun; 39(6):553-563. PubMed ID: 29668513
[TBL] [Abstract][Full Text] [Related]
5. Assessment of tumor response to definitive chemoradiotherapy and prognosis prediction in patients with esophageal cancer judged by PET response criteria in solid tumors: multicenter study in Japan.
Kitajima K; Kaida H; Nakatani K; Ishibashi M; Morita T; Nakajo M; Tamaki Y; Minamimoto R
Nucl Med Commun; 2020 May; 41(5):443-451. PubMed ID: 32187159
[TBL] [Abstract][Full Text] [Related]
6. Texture analysis of
Nakajo M; Jinguji M; Nakabeppu Y; Nakajo M; Higashi R; Fukukura Y; Sasaki K; Uchikado Y; Natsugoe S; Yoshiura T
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):206-214. PubMed ID: 27613542
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma.
Zhou M; Chen Y; Huang H; Zhou X; Liu J; Huang G
Oncotarget; 2016 Dec; 7(50):83544-83553. PubMed ID: 27835875
[TBL] [Abstract][Full Text] [Related]
8. Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.
Franko J; Voynov G; Goldman CD
Ann Thorac Surg; 2016 Mar; 101(3):1123-30. PubMed ID: 26652139
[TBL] [Abstract][Full Text] [Related]
9. Influence of Baseline Positron Emission Tomography in Metastatic Gastroesophageal Cancer on Survival and Response to Therapy.
Abdelhakeem A; Patnana M; Wang X; Rogers JE; Murphy MB; Sagebiel T; Ikoma N; Badgwell BD; Trail A; Estrella JS; Lu Y; Devine C; Ajani JA
Oncology; 2021; 99(10):659-664. PubMed ID: 34352788
[TBL] [Abstract][Full Text] [Related]
10. Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation.
Suzuki A; Xiao L; Taketa T; Sudo K; Wadhwa R; Blum MA; Skinner H; Komaki R; Weston B; Lee JH; Bhutani MS; Rice DC; Maru DM; Erasmus J; Swisher SG; Hofstetter WL; Ajani JA
Ann Oncol; 2013 Nov; 24(11):2854-9. PubMed ID: 23994746
[TBL] [Abstract][Full Text] [Related]
11. Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database.
Vlacich G; Samson PP; Perkins SM; Roach MC; Parikh PJ; Bradley JD; Lockhart AC; Puri V; Meyers BF; Kozower B; Robinson CG
Cancer Med; 2017 Dec; 6(12):2886-2896. PubMed ID: 29139215
[TBL] [Abstract][Full Text] [Related]
12. Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma.
Hofheinz F; Li Y; Steffen IG; Lin Q; Lili C; Hua W; van den Hoff J; Zschaeck S
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1485-1494. PubMed ID: 30949816
[TBL] [Abstract][Full Text] [Related]
13. Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.
Abd El-Hafez YG; Moustafa HM; Khalil HF; Liao CT; Yen TC
Oral Oncol; 2013 Mar; 49(3):261-8. PubMed ID: 23036774
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS
Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243
[TBL] [Abstract][Full Text] [Related]
15. Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes.
Shao MS; Wong AT; Schwartz D; Weiner JP; Schreiber D
Ann Thorac Surg; 2016 Jun; 101(6):2148-54. PubMed ID: 27016842
[TBL] [Abstract][Full Text] [Related]
16. Staging and Response Evaluation to Neo-Adjuvant Chemoradiation in Esophageal Cancers Using 18FDG PET/ CT with Standardized Protocol.
Fatima N; Zaman MU; Zaman A; Zaman U; Tahseen R; Zaman S
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2003-2008. PubMed ID: 31350957
[TBL] [Abstract][Full Text] [Related]
17. 18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients.
Elimova E; Wang X; Etchebehere E; Shiozaki H; Shimodaira Y; Wadhwa R; Planjery V; Charalampakis N; Blum MA; Hofstetter W; Lee JH; Weston BR; Bhutani MS; Rogers JE; Maru D; Skinner HD; Macapinlac HA; Ajani JA
Eur J Cancer; 2015 Nov; 51(17):2545-52. PubMed ID: 26321501
[TBL] [Abstract][Full Text] [Related]
18. A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer.
Hayashi Y; Xiao L; Suzuki A; Blum MA; Sabloff B; Taketa T; Maru DM; Welsh J; Lin SH; Weston B; Lee JH; Bhutani MS; Hofstetter WL; Swisher SG; Ajani JA
Eur J Cancer; 2012 Dec; 48(18):3396-404. PubMed ID: 22853875
[TBL] [Abstract][Full Text] [Related]
19. A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246.
Swisher SG; Winter KA; Komaki RU; Ajani JA; Wu TT; Hofstetter WL; Konski AA; Willett CG
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1967-72. PubMed ID: 21507583
[TBL] [Abstract][Full Text] [Related]
20. Trends in Treatment of T1N0 Esophageal Cancer.
Semenkovich TR; Hudson JL; Subramanian M; Mullady DK; Meyers BF; Puri V; Kozower BD
Ann Surg; 2019 Sep; 270(3):434-443. PubMed ID: 31274653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]